Background. We used functional connectivity measures from brain resting state functional magnetic resonance imaging to identify human neural correlates of sedation with dexmedetomidine or propofol and their similarities with natural sleep. Methods. Connectivity within the resting state networks that are proposed to sustain consciousness generation was compared between deep non-rapid-eye-movement (N3) sleep, dexmedetomidine sedation, and propofol sedation in volunteers who became unresponsive to verbal command. A newly acquired dexmedetomidine dataset was compared with our previously published propofol and N3 sleep datasets. Results. In all three unresponsive states (dexmedetomidine sedation, propofol sedation, and N3 sleep), within-network functional connectivity, including thalamic functional connectivity in the higher-order (default mode, executive control, and salience) networks, was significantly reduced as compared with the wake state. Thalamic functional connectivity was not reduced for unresponsive states within lower-order (auditory, sensorimotor, and visual) networks. Voxel-wise statistical comparisons between the different unresponsive states revealed that thalamic functional connectivity with the medial prefrontal/anterior cingulate cortex and with the mesopontine area was reduced least during dexmedetomidine-induced unresponsiveness and most during propofol-induced unresponsiveness. The reduction seen during N3 sleep was
The mechanistic similarities or differences between physiological sleep and pharmacologically induced altered conscious states remain poorly understood. The a 2 -adrenergic agonist sedative dexmedetomidine produces a behavioural state similar to sleep, with overlapping electroencephalogram (EEG) characteristics. 1 Moderate sedation with dexmedetomidine is known to produce EEG changes similar to those seen during stage 2 non-rapid eye movement (NREM) sleep (N2), namely slow-delta oscillations and spindles. 2 Spindles are composed of bursts of 9-15 Hz oscillations that last 1-2 s. Deeper unresponsive dexmedetomidine sedation produces strong slow-delta activity (0-4 Hz) without spindles, similar to stage 3 NREM sleep (N3). 2 This likely occurs through the promotion of endogenous sleep pathway activities. 3 Dexmedetomidine inhibits locus coeruleus-derived noradrenergic neurotransmission to the ventrolateral preoptic nucleus (VLPO), thus disinhibiting the VLPO and provoking an inhibition of cortical arousal nuclei. Hence we previously hypothesized that dexmedetomidine produces a restorative brain state similar to sleep, unlike the state produced by alternative sedatives. 4 Several studies have advocated that other sedatives, including propofol, also act through the promotion of subcortical sleep pathways. 5 However, human experimentation suggests the cortex is the primary target; 6 through augmenting the effects of c-amino-butyric acid(GABA)-ergic inhibitory interneurons. 7 Hence it is possible that, while both dexmedetomidine and propofol modulate bottom-up pathways, propofol exerts more profound cortical effects, manifesting as changes in connectivity. Dexmedetomidine has unique clinical properties compared with other sedative agents: it has been shown to reduce the burden of delirium in the critical care unit compared with benzodiazepine and propofol, 8 prevent delirium in elderly patients after non-cardiac major surgery, 9 and reduce agitation upon recovery in children. 10 It has been hypothesized that the mechanisms behind the relative protective effect of dexmedetomidine against delirium depends in part on its more natural restorative sleep-promoting actions. 4 A further important facet of dexmedetomidine sedation is that the patient can recover purposeful responsiveness after the application of a salient stimulus. 11 This distinguishes dexmedetomidine from other agents like propofol, which usually require cessation of administration to obtain sentient responsiveness.
To quantify the degree of neurobiological similarity between sleep, dexmedetomidine and propofol sedation and to identify the functional structures at the origin of patient rousability under dexmedetomidine sedation, a detailed functional comparison between these different brain states in humans is necessary.
In this study we used resting state functional magnetic resonance imaging (rs-fMRI) to examine differences in brain resting state functional connectivity (rs-FC) between dexmedetomidine sedation, propofol sedation, and N3 sleep. Previous studies have shown a disruption of resting state connectivity networks (RSNs) by anaesthetic agents and during sleep. The default mode network (DMN, associated with self-related mentation) 12 is altered during propofol-induced unresponsiveness 13 and N3 sleep.
14 DMN disruption may even be considered as a biomarker of altered consciousness. 15 Furthermore, the connectivity of other important RSNs, such as the executive control networks (left and right ECNs), 16 and the salience network 17 is also important to consciousness. The ECNs are associated with executive function and awareness of the environment, 16 while the salience network manages interaction with the environment and responses to relevant 'salient' sensory stimuli (such as being asked to respond to one's own name). 18 Within those networks we were specifically interested in whether connectivity involving the thalamus and the anterior cingulate cortex (ACC) was differentially modified by dexmedetomidine, propofol, or N3 sleep-notably because these regions are known to be part of the brain's arousal/salience system. In order to provide a comprehensive overview of the modified neural networks, we also analysed the auditory, sensorimotor, and visual RSNs. A methodological strength of this work is the simultaneous analysis of three datasets, using the same acquisition parameters and data analysis steps, allowing comparison of wakefulness with all three unresponsive states.
Materials and methods

Subjects
We used three datasets for our analysis. The dexmedetomidine dataset consisted of 11 healthy subjects (age range 19-29 years) and was acquired between November 11, 2012, and June 21, 2013. The propofol dataset has been published before 13 19 20 and consisted of 17 subjects (age range 18-31 years). The also previously published 21 N3 sleep dataset consisted of 12 subjects (age range 18-25 years). The studies were approved by the Ethics Committee of the Faculty of Medicine of the University of Liè ge,
Editors key points
• Regional changes in neuronal activity can be detected by functional magnetic resonance imaging.
• Functional connectivity assesses the correlation between the neuronal activity of different regions and networks.
• Connectivity within the default mode network (DMN) is thought to be important for consciousness.
• The authors compared DMN connectivity during deep non-REM sleep and deep sedation with propofol and dexmedetomidine.
Liè ge, Belgium, and subjects gave written informed consent (Committee number: 707; EudraCT number: 2012-003562-40; internal reference: 20121/135; accepted on August 31, 2012; Chair: Prof G. Rorive).
Sedation protocols and determination of sleep stages and level of consciousness Propofol and dexmedetomidine subjects fasted for at least 6 h prior to sedation. They wore headphones and earplugs in the scanner. Propofol or dexmedetomidine infusions were achieved using a target-controlled infusion device, which incorporates the three-compartment pharmacokinetic model of Marsh for propofol 22 and the height-adjusted model of Dyck 23 for dexmedetomidine to obtain constant concentrations. Infusions occurred through a catheter placed into a vein of the forearm or hand. Blood pressure, pulse oximetry, breathing frequency, and electrocardiogram (ECG) were monitored during the whole experiment. Subjects were breathing spontaneously at all times, while additional oxygen was delivered at 5 litres min À1 through a loosely fitting plastic facemask. The target concentration of propofol or dexmedetomidine was adjusted by steps of 0.5 mg (for propofol) or ng ml À1 (for dexmedetomidine) to obtain four different sedation levels, namely baseline (no-drug condition), mild sedation, deep sedation (unresponsiveness to command), and recovery. Only data recorded during baseline and unresponsiveness will be considered here. The level of consciousness was assessed immediately before and after each scanning session. For each assessment the subjects were asked twice (using a loud voice) to strongly squeeze the hand of the investigator. During wakefulness (before sedation) the volunteers responded with a strong squeeze of the hand, while during deep sedation (unresponsiveness) there was no response.
After reaching the desired effect-site concentration, a 5-10-min period allowed for equilibration of concentrations between body compartments before assessment of the level of consciousness. An arterial blood sample was drawn before and after each scanning session for further determination of anaesthetic agent concentration and partial pressure of arterial carbon dioxide (pCO 2 ). Blood sampling occurred through a 20-G arterial catheter placed in the radial artery under local anaesthesia before starting data acquisition. Two certified anaesthesiologists and complete resuscitation equipment were present throughout the experiment (for Supplementary protocol information, see Boveroux et al.) 13 Propofol and dexmedetomidine volunteers were equipped with 64 EEG scalp electrodes to allow for simultaneous EEG recording during fMRI data acquisition (Brain Amp magnetic resonance compatible acquisition setup; Brain Products, Gilching, Germany). In this report, data analysis has been restricted to fMRI data only.
Sleep stage was determined using EEG measurements taken using the two above-mentioned MR-compatible 32-channel amplifiers and an MR-compatible EEG cap (Braincap MR; Falk Minow Services, Breitbrunn, Germany) with 64 ring-type electrodes, as described in Boly et al. 21 Functional MRI data from sleeping subjects presenting strong delta EEG activity were considered as having been recorded during N3 sleep and were selected for further analysis.
Data acquisition
For all datasets, T2*-weighted functional images were acquired on a 3-T scanner (Siemens Allegra scanner; Echo Planar Imaging sequence using 32 slices; matrix size 64 Â 64 Â 32; repetition time¼2460 ms; echo time¼40 ms; flip angle¼90 ; voxel size¼3.5
Â3.5Â3.0 mm 3 ; field of view¼220). For propofol and dexmedetomidine, acquisitions were made during the different levels of consciousness: wakefulness and unresponsiveness. For each experimental condition and each subject, the average number of scans was 253 (SD 74) for the propofol dataset, 296 (SD 29) for the dexmedetomidine dataset, and 234 (SD 81) for the N3 sleep dataset. For all subjects, a high-resolution T1-weighted image was acquired for coregistration purposes.
Data analysis and statistics
We used SPM8 software (Statistical Parametric Mapping, Wellcome Trust Centre for Neuroimaging; www.fil.ion.ucl.ac.uk) (accessed 31 August 2017) to realign, normalize, smooth (8 mm), and analyse the data. Movement artefact reduction software was applied (ArtRepair; http://cibsr.stanford.edu/tools/human-brain-project/ artrepair-software.html) (accessed 31 August 2017) and data were temporally bandpass filtered (0.007-0.1 Hz). We performed a seedbased analysis to investigate correlations between low-frequency blood oxygenation level-dependent signals in selected seed regions and the rest of the brain to examine RSN connectivity. The regions selected for the analyses were based on RSNs described in the literature. 13 24-26 These were (using MNI coordinates) the poste- . Connectivity with the thalamus was also examined (À7, -16, 6 and 7, À16, 6, combined). 13 20 Spheres with a diameter of 8 mm around these coordinates were used as seed regions. Movement parameters as well as white matter and cerebrospinal fluid parameters were used for removal of sources of noise in the rs-fMRI data. 13 For statistical analysis, we grouped fMRI data into four sets. The first set consisted of data recorded in subjects who had lost responsiveness to verbal command due to propofol (propofol group), the second set was those who had lost responsiveness due to dexmedetomidine (dexmedetomidine group), the third consisted of data recorded in subjects in N3 sleep (sleep group), and the fourth set was a combination of the wakefulness before sedation/before N3 sleep data from all subjects (wakefulness group). For each RSN seed region, these groups were contrasted and results were thresholded with a false discovery rate (FDR)-corrected P<0.05 at the wholebrain level. For the contrasts wakefulness>unresponsiveness, results were presented with an uncorrected P<0.001 when no results were obtained with an FDR-corrected P<0.05.
The within-and between-subjects comparison of the arterial pCO 2 in the dexmedetomidine and propofol group across experimental conditions was performed using a two-way mixed-design analysis of variance and Tukey honestly significant difference tests for post hoc comparisons. A two-tailed P-value <0.05 was considered statistically significant.
Results
All seven RSNs and thalamic rs-FC were reliably detected during wakefulness. There were no adverse events to report following dexmedetomidine and propofol sedation. Mean propofol plasma concentrations for wakefulness and unresponsiveness were 0 (SD 0) and 3.06 (SD 1.01) mg ml À1 , respectively. For dexmedetomidine, these values were 0 (SD 0) and 4.0 (SD 1.2) ng ml À1 , respectively.
Thalamic connectivity
In the group of wakeful subjects, the thalamus connected to the bilateral middle/superior frontal gyri, anterior cingulate gyrus, brainstem, bilateral inferior parietal lobules, and posterior cingulate gyrus/precuneus (Fig. 1A, Supplementary Table S1 of the Appendix). These regions are classically associated with the DMN, ECN, and salience networks. Significantly reduced rs-FC in these regions was found to be associated with unresponsiveness induced by dexmedetomidine, propofol, and N3 sleep. However, when contrasting dexmedetomidineinduced unresponsiveness with propofol and sleep, relatively preserved rs-FC was found in the bilateral middle/superior frontal gyri, anterior cingulate gyrus, and brainstem in dexmedetomidine-induced unresponsiveness ( Fig. 2 and Table  1 ). Contrasting N3 sleep with propofol-induced unresponsiveness showed that rs-FC in these regions was relatively preserved during N3 sleep as compared with propofol-induced unresponsiveness.
Default mode network
During wakefulness, the DMN consisted of the anterior cingulate gyrus, bilateral middle/superior frontal gyri, thalamus, brainstem, bilateral middle temporal gyri, bilateral parahippocampal gyri, posterior cingulate gyrus/precuneus, and inferior parietal lobules (Fig. 1, Supplementary Table S1 of the Appendix). Significantly reduced rs-FC in the thalamus and brainstem was found for all conditions of unresponsiveness. Dexmedetomidine-and propofol-induced unresponsiveness was associated with impaired anterior cingulate gyrus rs-FC. Sleep was associated with reduced rs-FC of the posterior cingulate gyrus/precuneus. During propofol-induced unresponsiveness, significantly maintained rs-FC was found in the posterior cingulate gyrus/precuneus as compared with N3 sleep (Fig. 2 , Table 1 ).
Executive control networks
During wakefulness, the bilateral ECNs consisted of the bilateral inferior/middle frontal gyri, anterior cingulate gyrus, thalamus, brainstem, and bilateral inferior/superior parietal lobules (Fig. 1 , Supplementary Table S1 of the Appendix). For both the left and right ECN, all types of loss of responsiveness were associated with impaired connectivity within those networks (Fig. 1 , Supplementary Table S1 of the Appendix). No significant differences were found between the different states of unresponsiveness. N3 sleep was found to be associated with significantly preserved rs-FC in the bilateral superior parietal lobules as compared with propofol-and dexmedetomidine-induced unresponsiveness (Fig. 2, Table 1 ).
Salience network
The salience network consisted of the bilateral inferior/middle frontal gyri, anterior cingulate gyrus, thalamus, brainstem, and bilateral inferior parietal lobules during wakefulness (Fig. 1 , Supplementary Table S1 of the Appendix). Significantly reduced rs-FC in these regions, with the exception of the left inferior frontal gyrus and brainstem, was found for states of unresponsiveness as compared with the wake state. No significant differences were found in rs-FC within the salience network between the different types of unresponsiveness.
Auditory network
During wakefulness, the auditory network consisted of the cingulate gyrus, bilateral superior temporal gyri/insula, brainstem, and thalamus (Fig. 1, Supplementary Table S1 of the Appendix). Significantly reduced rs-FC was found in the bilateral superior temporal gyri/insula for all unresponsive states as compared with the wake state. Within the auditory network, connectivity of the cingulate gyrus and bilateral superior temporal gyri/ insula was found to be significantly preserved during N3 sleep as compared with propofol-induced unresponsiveness (Fig. 2,  Table 1 ).
Sensorimotor network
The sensorimotor network consisted of the bilateral middle frontal gyri, anterior cingulate gyrus, paracentral lobule, thalamus, and bilateral superior temporal gyri/insula (Fig. 1,  Supplementary Table S1 of the Appendix). Significantly reduced rs-FC, associated with loss of responsiveness of either kind as compared with the wake state, was found in the bilateral superior temporal gyri/insula. No significant connectivity differences were found between the different types of unconsciousness.
Visual network
The visual network consisted of the thalamus, left parahippocampal gyrus, and cuneus during wakefulness (Fig. 1, Supplementary  Table S1 of the Appendix). Significantly impaired rs-FC of the left middle/superior temporal gyrus (detectable during wakefulness at P<0.005, uncorrected) was found during propofol-induced unresponsiveness and N3 sleep as compared with the wake state. Sleep-induced unresponsiveness was shown to be associated with a significantly higher rs-FC of the posterior cingulate gyrus/cuneus as compared with dexmedetomidine-and propofol-induced unresponsiveness (Fig. 2, Table 1 ).
Discussion
During wakefulness, rs-FC in the examined RSNs was comparable to that found in the literature. 17 24 With loss of responsiveness occurring during N3 sleep and dexmedetomidine and propofol sedation, decreases in rs-FC were seen in the higher-order RSNs (DMN, ECN, and salience network), 13 20 including a breakdown of thalamic connectivity within these networks. In the lower-order RSNs (auditory, sensorimotor, and visual RSNs), we detected a number of disconnections that might underlie impaired network integrity and multimodal communication between these RSNs during unresponsiveness 13 but no decrease in rs-FC in the thalamus. Thus rs-FC disruption within higher-order RSNs appears to be a hallmark of the unresponsive state. 13 16 20 27 28 This has significant ramifications for understanding the neurobiological overlap between natural sleep and pharmacologically induced alteration of consciousness.
Functional differences between types of unresponsiveness
Between states of unresponsiveness we observed variation in the extent to which thalamic rs-FC of higher-order RSNs was impaired. This was predominantly reflected in the variation of thalamic rs-FC in the ACC/medial prefrontal cortex, which was relatively preserved during dexmedetomidine-induced unresponsiveness as compared with N3 sleep and propofol-induced unresponsiveness as well as during N3 sleep as compared with propofol-induced unresponsiveness. The relative preservation of this rs-FC when using dexmedetomidine as compared with propofol could underlie the preserved potential of rapid recovery of information transmission in higher-order cognitive networks and the potential of a rapid return to oriented consciousness. Similarly, thalamic connectivity with the mesopontine region was found to be preserved during dexmedetomidineinduced unresponsiveness as compared with N3 sleep and propofol-induced unresponsiveness and during N3 sleep as compared with propofol-induced unresponsiveness. The mesopontine region is a key component of the ascending reticular arousal system and disruption of this area has previously been found to result in a state of unresponsiveness resembling general anaesthesia. 29 It is known to operate in close association with the thalamus to orchestrate attentional and arousal processes. 30 Therefore, disrupted connectivity between the brainstem, thalamus, and ACC/medial prefrontal cortex A left or right view of the internal face of the brain was chosen as a function of the presence of significant clusters or not. When no significant clusters were visible on one view, the other one was chosen.
(a region known to play an important role in saliency detection) 30 might result in reduced ability to induce and direct brain arousal. However, a possible link between the degree to which this particular connectivity is impaired and unresponsiveness could not be deduced from our study since all our volunteers were unresponsive. Positron emission tomography studies have shown that restored regional activity in the brainstem, thalamus, and ACC is associated with recovery of consciousness after propofol-and dexmedetomidine-induced loss of responsiveness 31 and with the transition from NREM to REM sleep. 32 In line with these results, our findings of relative connectivity preservation between the thalamus, mesopontine area, and areas of the higher-order RSNs (especially the ACC/medial prefrontal cortex saliency region) during dexmedetomidine sedation support the hypothesis that such preserved connectivity is essential for the brain to keep the potential of quickly recovering higher-order RSN connectivity, and thus cognition and awareness. Developing sedative regimens that preserve rs-FC in these key regions could be essential for ensuring patient rousability. Finally, as several connectivity differences were found between dexmedetomidine-induced unresponsiveness and N3 sleep, it remains unclear whether dexmedetomidine produces a sleeplike 'restorative state'. Of note, propofol unresponsiveness was associated with preserved DMN connectivity in the posterior cingulate gyrus/precuneus as compared with N3 sleep. In contrast, N3 sleep showed preserved ECN connectivity with the bilateral superior parietal lobules compared with propofol-and dexmedetomidineinduced unresponsiveness. DMN, ECN, and their anti-correlated activities are known to play a major role in functional communication and interaction with the environment. 33 Interactions between those two networks are frequently, if not always, observed during sedation with anaesthetic agents, including propofol 13 and even ketamine. 34 During ketamine-induced unresponsiveness, ECN connectivity is preserved while anticorrelation with DMN disappears. The differences in DMN and ECN interactions between propofol, dexmedetomidine, and N3 sleep alterations could underlie differences in the degree to which arousal and the ability to interact with the environment is impaired. This point deserves specifically dedicated investigations.
Methodological considerations
rs-fMRI analyses can be done using several techniques, of which independent component analysis (ICA) and seed-based methods are most frequently employed. 33 ICA necessitates only very limited a priori knowledge about spatial constraints and is thought to excellently separate artefact activations from neuronal activations. However, concerns exist about the number of components the signal should be divided into in altered states of consciousness, 35 how to best discriminate between neuronal and non-neuronal independent components, 36 and how to choose the independent component representing a specific RSN of interest. Such constraints might interfere with the detection of the RSNs. Given proper preprocessing, seed-based analysis is thought to excellently detect connectivity from an RSN core node to other brain regions, thus providing trustworthy RSN connectivity results. This determined our choice for the use of seed-based analysis. A possible reason for carefulness when interpreting fMRI data might be the potential influence of the arterial pCO 2 -induced cerebral vasodilation effect on the blood oxygen leveldependent (BOLD) signal. However, it has been demonstrated that increases in arterial CO 2 in the range of 20% do not modify the haemodynamic response to neural activation. 37 In addition, rs-fMRI studies look at between-region correlations in BOLD signal fluctuation, not at task-induced regional activations. In that case, even if an increase in arterial pCO 2 provokes a vasodilation, it will not influence correlations between brain regions. Arterial pCO 2 may change during propofol and dexmedetomidine sedation. By measuring arterial pCO 2 , we wished to rule out large increases. This was not the case since this increase as compared with baseline was 22% in the propofol group and 13% in the dexmedetomidine group (Table 2) . We are therefore confident pCO 2 levels did not significantly influence our results. The same kind of reasoning applies to cerebral haemodynamic changes that could have modified the BOLD signal independently during anaesthetic agent-induced alteration of consciousness. This possibility is unlikely, insofar as haemodynamic parameters remained stable during propofol and dexmedetomidine sedation and did not require any external intervention to maintain them in the normal range. Despite possible interference of those agents with cerebral blood flow autoregulation, 38 propofol and dexmedetomidine are thought to have had little direct effect on cerebral flow-metabolism coupling, and hence on the BOLD signal, independent from their effect on brain activity. 39 40 Another potential confounder in rs-fMRI studies is the influence of movements during data acquisition. Motion artefact software parameters indicated that no significant data disturbance was to be expected as a result of movement in any of the analysed groups. An inherent limitation of comparing states with altered levels of consciousness, namely propofol sedation, dexmedetomidine sedation, and natural sleep, is the possibility that we were actually comparing vastly different depths of the alterations in consciousness. We are confident in achieving comparable clinical states with propofol and dexmedetomidine, insofar as their administration was slowly titrated in small steady-state steps of 0.5 mg ml À1 or ng ml À1 , respectively, to the loss of response to verbal command and not beyond. In our sleep group, sleep stage assessment was achieved using electrophysiological criteria, ending with a selection of N3 sleep data. During such sleep stages, connectedness to the environment is abolished. 18 Nonetheless, the patients in this state were unresponsive, similar to the drug-induced states. It is intriguing that unresponsive dexmedetomidine sedation and N3 sleep differ in terms of connectivity between the thalamus and the medial prefrontal/anterior cingulate cortex and between the thalamus and the mesopontine area. Similar differences are also seen between unresponsive propofol and dexmedetomidine sedation. These offer preliminary insights into how the brain may rapidly reorient on emergence from dexmedetomidine but may not as easily from propofol and N3 sleep. Indeed, when administered ; similarly N3 sleep is associated with no recall of any mental content $40% of the time. 42 In contrast, the dexmedetomidine state, while associated with a lack of real-time behavioural responses, is associated with no recall of consciousness experiences $30% of the time. 43 Despite similar incidences of dreaming during N3 sleep and dexmedetomidine sedation, we hypothesize that during dexmedetomidine sedation, brain regions supporting consciousness and cognition are more prone to regain efficient connectivity, allowing the rapid reorientation of cognition on emergence. This hypothesis should be tested in future studies. Wakeful brain states may have differed to some degree between groups of volunteers, because subjects that were scheduled to receive a sedative agent such as propofol or dexmedetomidine may have been more nervous/attentive than those who were scheduled to be scanned during normal sleep. Comparing each wake state to its corresponding unresponsive state could have led to findings that were related to differences between wake states and not to differences between unresponsive states. Insofar as this study mainly aimed at finding differences between three different unresponsive states, wake data were grouped to smooth the effect of different expectations during the wake state. However, this grouping has had little effect on our findings, at least for those networks we were focused on, because the modifications we found for the unresponsive states were highly comparable to those already reported in the literature for propofol, 13 20 dexmedetomidine, 31 and N3 sleep. 14 Based on this strong a priori knowledge, this is also the reason why we decided to consider some of the results of these contrasts as being statistically significant at the uncorrected P<0.001 threshold. Our sample size is relatively small (11 for the dexmedetomidine group, 17 for the propofol group, and 12 for the N3 sleep group). The observed significant effects are reported at a conservative FDR-corrected statistical threshold and are therefore robust. Using a random effects approach at the group level allows confidence that these results are representative of the sampled population. A sample size of 20 subjects is generally considered optimal in studies such as this one, 44 but our sample size is in the range of most published fMRI studies investigating the effect of sedation (between 7 and 19). 13 However, our limited sample size may have prevented us from finding smaller differences between groups.
Conclusions
With our study, we aimed to find similarities and differences between wakefulness, dexmedetomidine-induced unresponsiveness, propofol-induced unresponsiveness, and N3 sleep. Disconnection within the higher-order cortical RSNs appeared to be a general biomarker of lost responsiveness. In addition, an important role for the upper brainstem arousal areas could be deduced. Connectivity between the thalamus and the brainstem and ACC/medial prefrontal cortex was found to be more preserved when using dexmedetomidine as compared with propofol. This provides a candidate mechanism for explaining why rapid recovery of consciousness and cognition is possible with dexmedetomidine-but not propofol-induced unresponsiveness.
